Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bionano Genomics, Inc. (BNGO) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bionano Genomics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1411690.
Total stock buying since 2018: $322,361.
Total stock sales since 2018: $72,400.
Total stock option exercises since 2018: $98,279.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 130,789 | $93,044 | 0 | $0 | 0 | $0 |
| 2022 | 10,000 | $16,000 | 20,000 | $72,400 | 124,470 | $63,879 |
| 2021 | 5,025 | $20,024 | 0 | $0 | 47,500 | $26,600 |
| 2019 | 0 | $0 | 0 | $0 | 6,000 | $7,800 |
| 2018 | 31,339 | $193,293 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-06 | 65,789 | $49,999 | 0 | $0 | 0 | $0 |
| 2023-05 | 65,000 | $43,045 | 0 | $0 | 0 | $0 |
| 2022-08 | 0 | $0 | 20,000 | $72,400 | 20,000 | $7,600 |
| 2022-07 | 0 | $0 | 0 | $0 | 44,470 | $22,679 |
| 2022-05 | 10,000 | $16,000 | 0 | $0 | 60,000 | $33,600 |
| 2021-11 | 5,025 | $20,024 | 0 | $0 | 22,500 | $12,600 |
| 2021-05 | 0 | $0 | 0 | $0 | 25,000 | $14,000 |
| 2019-01 | 0 | $0 | 0 | $0 | 6,000 | $7,800 |
| 2018-08 | 31,339 | $193,293 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-13 | Mamuszka Hannah | Buy | 65,789 | .76 | 49,999 |
| 2023-05-16 | Holmlin R. Erik (President and CEO) | Buy | 15,000 | .64 | 9,645 |
| 2023-05-12 | Stewart Christopher P. (Chief Financial Officer) | Buy | 50,000 | .67 | 33,400 |
| 2022-08-15 | Linney Yvonne | Sale | 20,000 | 3.62 | 72,400 |
| 2022-08-15 | Linney Yvonne | Option Ex | 20,000 | .38 | 7,600 |
| 2022-07-07 | Barker David L | Option Ex | 44,470 | .51 | 22,679 |
| 2022-05-16 | Barker David L (Director) | Buy | 10,000 | 1.60 | 16,000 |
| 2022-05-13 | Stewart Christopher P. (Chief Financial Officer) | Option Ex | 60,000 | .56 | 33,600 |
| 2021-11-29 | Holmlin R. Erik (President and CEO) | Buy | 5,025 | 3.98 | 20,024 |
| 2021-11-19 | Stewart Christopher P. (Chief Financial Officer) | Option Ex | 22,500 | .56 | 12,600 |
| 2021-05-26 | Stewart Christopher P. (Chief Financial Officer) | Option Ex | 25,000 | .56 | 14,000 |
| 2019-01-18 | Borodkin Mark (Chief Operating Officer) | Option Ex | 6,000 | 1.30 | 7,800 |
| 2018-08-23 | Borodkin Mark (Chief Operating Officer) | Buy | 815 | 6.12 | 4,991 |
| 2018-08-23 | Holmlin R. Erik (President and CEO) | Buy | 1,630 | 6.12 | 9,983 |
| 2018-08-23 | Halak Brian K (10% Owner) | Buy | 15,000 | 6.12 | 91,875 |
| 2018-08-23 | Twomey Christopher J (Director) | Buy | 10,000 | 6.12 | 61,250 |
| 2018-08-21 | Barker David L (Director) | Buy | 3,894 | 6.47 | 25,194 |
Insider trading activities including stock purchases, stock sales, and option exercises of BNGO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bionano Genomics, Inc. (symbol BNGO, CIK number 1411690) see the Securities and Exchange Commission (SEC) website.